Abiopharma

News list

Wright Frederick Craig 🟢 acquired 53.7K shares (1 derivative) of AerSale Corp (ASLE) at $5.77 Transaction Date: Aug 19, 2026 | Filing ID: 099733

Full text

News bot Aug. 21, 2026, 9:02 p.m.
🔍 Wright Frederick Craig (Executive)

Company: AerSale Corp (ASLE)

Report Date: 2026-08-19
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 53,674
- Total shares held: 2,000
Detailed Transactions and Holdings:
- Acquired 17,331 shares of Common Stock (Direct)
  Date: 2026-08-19 | Code: A | equity_swap_involved: 0 | shares_owned_after: 230,862.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-19 | Code: H | nature_of_ownership: By F.C. Wright Revocable Trust | shares_owned_after: 2,000.00
- Acquired 36,343 shares of Stock Option (right to buy) at $5.77 per share (Derivative)
  Date: 2026-08-19 | Code: A | Expires: 2036-08-19 | equity_swap_involved: 0 | shares_owned_after: 102,881.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Represents an award of restricted stock units granted under the AerSale Corporation 2020 Equity Incentive Plan, as amended (the "Plan"), that will vest in one-third increments on each of June 7, 2027, June 7, 2028, and June 7, 2029.
- F2: Represents stock options granted under the Plan that will vest in one-third increments on each of June 7, 2027, June 7, 2028, and June 7, 2029.
- REMARKS: Senior Vice President and Head of Asset Management